- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 32.1
Statement of Chief Executive Officer and Chief Financial Officer
Pursuant to Section 1350 of Title 18 of the United States Code
Pursuant to Section 1350 of Title 18 of the United States Code as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Ryan Drexler and Sabina Rizvi, the Chief Executive Officer and Chief Financial Officer, respectively, of MusclePharm Corporation (the “Company”), hereby certify that based on the undersigned’s knowledge:
1. The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 16, 2022 | /s/ Ryan Drexler |
Ryan Drexler | |
Chief Executive Officer and Chairman of the Board of Directors | |
(Principal Executive Officer) |
Date: May 16, 2022 | /s/ Sabina Rizvi |
Sabina Rizvi | |
Chief Financial Officer and President | |
(Principal Financial and Accounting Officer) |
-1- |